1. The Nurse View: Management of Pancreatic Cancer

3. Activity Goals

4. Introduction

5. Introduction (cont)

6. Presenting Signs and Symptoms

7. Diagnosis and Staging

8. Diagnosis and Surgical Treatment

9. Treatment of Advanced Disease

10. Advances in Past 4 Years

11. Gemcitabine: Standard of Care?

12. Considerations When Choosing Treatment Options

13. PRODIGE 4/ACCORD 11 Study: Better Survival With FOLFIRINOX

14. PRODIGE 4/ACCORD 11: Safety

15. FOLFIRINOX: Managing Adverse Effects

16. FOLFIRINOX: Adverse Effects

17. FOLFIRINOX: Managing Adverse Effects (cont)

18. Symptom Management: Diarrhea

19. Why Is Pancreatic Cancer So Hard to Treat?

20. Nab-paclitaxel Targets the Stroma

22. MPACT Study: Better Survival With GEM + Nab-Paclitaxel vs GEM Alone

23. Summary of Overall Survival

24. Making Treatment Decisions

25. Comprehensive Care of Patients With Pancreatic Cancer

26. Coordination of Care

27. Clinical Trials

28. Clinical Trial Design

29. Encourage Clinical Trial Participation

30. Ongoing Trials

31. Abbreviations

32. Abbreviations (cont)

33. Abbreviations (cont)

34. References

35. References (cont)

36. References (cont)

37. References (cont)

38. References (cont)

39. References (cont)

40. References (cont)

41. References (cont)

42. References (cont)